Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1972 1
1974 1
1985 1
1992 1
1994 1
1995 1
1996 2
1998 2
1999 1
2001 1
2002 1
2003 2
2005 1
2006 1
2008 1
2009 1
2011 2
2012 4
2013 6
2014 9
2015 6
2016 7
2017 4
2018 3
2019 4
2020 10
2021 5
2022 12
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages.
Yuan D, Hu J, Ju X, Putz EM, Zheng S, Koda S, Sun G, Deng X, Xu Z, Nie W, Zhao Y, Li X, Dougall WC, Shao S, Chen Y, Tang R, Zheng K, Yan J. Yuan D, et al. Among authors: putz em. Proc Natl Acad Sci U S A. 2023 Nov 21;120(47):e2302126120. doi: 10.1073/pnas.2302126120. Epub 2023 Nov 15. Proc Natl Acad Sci U S A. 2023. PMID: 37967215
Bench to bedside: NK cells and control of metastasis.
Krasnova Y, Putz EM, Smyth MJ, Souza-Fonseca-Guimaraes F. Krasnova Y, et al. Among authors: putz em. Clin Immunol. 2017 Apr;177:50-59. doi: 10.1016/j.clim.2015.10.001. Epub 2015 Oct 23. Clin Immunol. 2017. PMID: 26476139 Review.
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma.
Grissenberger S, Sturtzel C, Wenninger-Weinzierl A, Radic-Sarikas B, Scheuringer E, Bierbaumer L, Etienne V, Némati F, Pascoal S, Tötzl M, Tomazou EM, Metzelder M, Putz EM, Decaudin D, Delattre O, Surdez D, Kovar H, Halbritter F, Distel M. Grissenberger S, et al. Among authors: putz em. Cancer Lett. 2023 Feb 1;554:216028. doi: 10.1016/j.canlet.2022.216028. Epub 2022 Dec 1. Cancer Lett. 2023. PMID: 36462556 Free article.
Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunity.
Delconte RB, Kolesnik TB, Dagley LF, Rautela J, Shi W, Putz EM, Stannard K, Zhang JG, Teh C, Firth M, Ushiki T, Andoniou CE, Degli-Esposti MA, Sharp PP, Sanvitale CE, Infusini G, Liau NPD, Linossi EM, Burns CJ, Carotta S, Gray DHD, Seillet C, Hutchinson DS, Belz GT, Webb AI, Alexander WS, Li SS, Bullock AN, Babon JJ, Smyth MJ, Nicholson SE, Huntington ND. Delconte RB, et al. Among authors: putz em. Nat Immunol. 2024 Feb;25(2):371-372. doi: 10.1038/s41590-023-01714-8. Nat Immunol. 2024. PMID: 38087084 No abstract available.
Diversity and trends of human milk banking: a scoping review from 1946 to 2021.
Siziba LP, Huhn S, Pütz E, Baier C, Peter RS, Gebauer C, Griffin S, Wedekind S, Shenker N, Genuneit J. Siziba LP, et al. Among authors: putz e. Arch Dis Child Fetal Neonatal Ed. 2023 May;108(3):210-216. doi: 10.1136/archdischild-2022-324499. Epub 2022 Oct 7. Arch Dis Child Fetal Neonatal Ed. 2023. PMID: 36207059 Review.
NK Cell-Specific CDK8 Deletion Enhances Antitumor Responses.
Witalisz-Siepracka A, Gotthardt D, Prchal-Murphy M, Didara Z, Menzl I, Prinz D, Edlinger L, Putz EM, Sexl V. Witalisz-Siepracka A, et al. Among authors: putz em. Cancer Immunol Res. 2018 Apr;6(4):458-466. doi: 10.1158/2326-6066.CIR-17-0183. Epub 2018 Jan 31. Cancer Immunol Res. 2018. PMID: 29386186
Clinical assessment in ischaemic cardiomyopathy.
Putz E, Vagelos R. Putz E, et al. Nucl Med Commun. 2002 Apr;23(4):341-5. doi: 10.1097/00006231-200204000-00007. Nucl Med Commun. 2002. PMID: 11930187 Review.
96 results